DNER and neoplasm: Reprogramming immune response by epigenetic modifications comes into play, when a dual BET/HAT inhibitor enhanced antigen presentation of PANC-1 cells and T cell recruitment to the tumor stroma, and sensitized PDAC cells to immune checkpoint inhibition and extended survival in the KPC mouse model of advanced PDAC [182].